Recent Study Published in Journal of Clinical Oncology Highlights Importance of Prognostic Biomarker for Uveal Melanoma
The results of the Collaborative Ocular Oncology Study Number 2 (COOG2) were published in the July 2024 issue of the Journal of Clinical Oncology and validated the prognostic accuracy of the integrated
read more
Dr. Abbey First in the World to Administer Novel Trispecific Fusion Antibody EB-105 for Diabetic Macular Edema as Part of Phase Ib LOTUS Clinical Trial
On July 9, Texas Retina Associates Director of Clinical Research for Dallas Ashkan Abbey, MD, dosed the first patient in the Phase Ib LOTUS trial of EB-105, the world’s first pentavalent trispecific
read more
July is UV Safety Month — Debunking Seven Common Myths About Sunglasses
When most people think of UV protection, they think of their skin and sunscreen. Did you know that long-term exposure to bright sunlight may also increase your risk of eye disease? July
read more
Monitoring Age-related Macular Degeneration at Home
As the leading cause of vision loss in older adults, age-related macular degeneration (AMD) is the most common reason patients are referred to Texas Retina. It happens when the central part of
read more
Protect Your Eyes as You Enjoy the April 8 Great American Eclipse
On April 8, 2024, North America will witness a rare total solar eclipse as the moon passes between the sun and the Earth, briefly blocking the sun’s rays for several minutes and darkening
read more
Honoring Our Physicians
Tomorrow, March 30, is National Doctor’s Day. At Texas Retina, we celebrate all 16 of our physicians as well as all of the physicians who care for our patients and communities. Thank
read more
Texas Retina Associates Led the Way at the 2024 VisionWalk to Benefit the Foundation Fighting Blindness
This past Saturday, Texas Retina Associates sponsored and participated in the 2024 Dallas-Fort Worth VisionWalk to benefit the Foundation Fighting Blindness and was recognized as the “Largest Team.” Our “Walk Stars” came
read more
Dr. Abbey Recognized as a 2023 Top 10 Reviewer for Ophthalmic Surgery Lasers + Imaging Retina Medical Journal
The medical journal Ophthalmic Surgery Lasers + Imaging Retina (OSLI Retina) recently recognized Texas Retina Associates’ Ashkan M. Abbey, MD as a “2023 Top 10 Reviewer” in recognition of the quantity, quality
read more
Shining a Spotlight on Age-related Macular Degeneration (AMD)
February is national age-related macular degeneration (AMD) and low vision awareness month. Low vision is a visual impairment that cannot be corrected by standard eyeglasses, contact lenses, medication, or surgery. AMD, a deterioration, or
read more Dr. Abbey Featured as a Panelist in Retina Times Article on Secondary IOL Placement Surgery
In the Winter 2023 issue of Retina Times published by the American Society of Retina Specialists (ASRS), Texas Retina Associates’ Ashkan M. Abbey, MD, was featured in an article titled, “Managing the
read more